EXPD vs. WST
EXPD (Expeditors International of Washington, Inc.) and WST (West Pharmaceutical Services, Inc.) are both stocks. EXPD operates in Integrated Freight & Logistics (Industrials), while WST operates in Medical Instruments & Supplies (Healthcare). Over the past 10 years, EXPD returned 13.98%/yr vs 15.91%/yr for WST. Their 0.27 correlation means their historical movements had little consistent relationship.
Performance
EXPD vs. WST - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, EXPD achieves a 13.25% return, which is significantly lower than WST's 24.21% return. Over the past 10 years, EXPD has underperformed WST with an annualized return of 13.98%, while WST has yielded a comparatively higher 15.91% annualized return.
EXPD
- 1D
- 0.53%
- 1M
- 0.19%
- 6M
- 5.12%
- YTD
- 13.25%
- 1Y
- 47.97%
- 3Y*
- 11.49%
- 5Y*
- 6.76%
- 10Y*
- 13.98%
- ALL TIME*
- 16.89%
WST
- 1D
- 0.40%
- 1M
- -6.71%
- 6M
- 47.73%
- YTD
- 24.21%
- 1Y
- 42.95%
- 3Y*
- -2.56%
- 5Y*
- -3.45%
- 10Y*
- 15.91%
- ALL TIME*
- 11.71%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $190.53M | $212.72M | $207.16M | |
| $362.83M | $291.60M | $272.21M |
EXPD vs. WST - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
EXPD Expeditors International of Washington, Inc. | 13.25% | 36.16% | -11.86% | 23.86% | -21.68% | 42.50% | 23.47% | 16.17% | 6.52% | 23.93% |
WST West Pharmaceutical Services, Inc. | 24.21% | -15.73% | -6.75% | 49.97% | -49.70% | 65.88% | 89.05% | 54.13% | -0.08% | 17.02% |
Correlation
The correlation between EXPD and WST is 0.33, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.33 |
Correlation (3Y) Balances recent behavior with more history. | 0.29 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.35 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.34 |
Correlation (All Time) Calculated using the full available price history since Mar 26, 1990 | 0.27 |
Fundamentals
EXPD:
$21.96B
WST:
$24.00B
EXPD:
$6.19
WST:
$7.82
EXPD:
27.12
WST:
43.62
EXPD:
2.03
WST:
7.41
EXPD:
9.85
WST:
8.13
EXPD:
$11.19B
WST:
$3.33B
EXPD:
$1.29B
WST:
$1.22B
EXPD:
$1.18B
WST:
$824.20M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
EXPD vs. WST — Risk / Return Rank
EXPD
WST
EXPD vs. WST - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Expeditors International of Washington, Inc. (EXPD) and West Pharmaceutical Services, Inc. (WST). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| EXPD | WST | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.25 | ||
| Sortino ratioReturn per unit of downside risk | +0.05 | ||
| Omega ratioGain probability vs. loss probability | 1.32 | 1.25 | +0.07 |
| Calmar ratioReturn relative to maximum drawdown | 2.91 | 1.75 | +1.16 |
| Martin ratioReturn relative to average drawdown | 7.32 | 3.78 | +3.55 |
Loading charts...
Drawdowns
EXPD vs. WST - Drawdown Comparison
The maximum EXPD drawdown since its inception was -58.07%, roughly equal to the maximum WST drawdown of -59.29%. Use the drawdown chart below to compare losses from any high point for EXPD and WST.
Loading charts...
Drawdown Indicators
| EXPD | WST | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -58.07% | -59.29% | +1.22% |
Max Drawdown (1Y)Largest decline over 1 year | -15.88% | -24.70% | +8.82% |
Max Drawdown (3Y)Largest decline over 3 years | -21.26% | -53.79% | +32.53% |
Max Drawdown (5Y)Largest decline over 5 years | -35.62% | -59.29% | +23.67% |
Max Drawdown (10Y)Largest decline over 10 years | -35.62% | -59.29% | +23.67% |
Current DrawdownCurrent decline from peak | -8.16% | -26.74% | +18.58% |
Average DrawdownAverage peak-to-trough decline | -13.59% | -16.92% | +3.33% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.29% | 11.41% | -5.12% |
Volatility
EXPD vs. WST - Volatility Comparison
The current volatility for Expeditors International of Washington, Inc. (EXPD) is 7.19%, while West Pharmaceutical Services, Inc. (WST) has a volatility of 9.56%. This indicates that EXPD experiences smaller price fluctuations and is considered to be less risky than WST based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| EXPD | WST | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.19% | 9.56% | -2.37% |
Volatility (6M)Calculated over the trailing 6-month period | 24.78% | 24.58% | +0.20% |
Volatility (1Y)Calculated over the trailing 1-year period | 30.54% | 34.01% | -3.47% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 26.91% | 40.73% | -13.82% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 25.17% | 34.73% | -9.56% |
Dividends
EXPD vs. WST - Dividend Comparison
EXPD's dividend yield for the trailing twelve months is around 0.94%, more than WST's 0.26% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EXPD Expeditors International of Washington, Inc. | 0.94% | 1.03% | 1.32% | 1.08% | 1.29% | 0.86% | 1.09% | 1.28% | 1.32% | 1.30% | 1.51% | 1.60% |
WST West Pharmaceutical Services, Inc. | 0.26% | 0.31% | 0.25% | 0.22% | 0.31% | 0.15% | 0.23% | 0.41% | 0.58% | 0.54% | 0.58% | 0.75% |
Financials
EXPD vs. WST - Financials Comparison
This section allows you to compare key financial metrics between Expeditors International of Washington, Inc. and West Pharmaceutical Services, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
EXPD vs. WST - Profitability Comparison
EXPD - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Expeditors International of Washington, Inc. reported a gross profit of 0.00 and revenue of 2.78B. Therefore, the gross margin over that period was 0.0%.
WST - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, West Pharmaceutical Services, Inc. reported a gross profit of 329.20M and revenue of 872.30M. Therefore, the gross margin over that period was 37.7%.
EXPD - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Expeditors International of Washington, Inc. reported an operating income of 294.83M and revenue of 2.78B, resulting in an operating margin of 10.6%.
WST - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, West Pharmaceutical Services, Inc. reported an operating income of 179.10M and revenue of 872.30M, resulting in an operating margin of 20.5%.
EXPD - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Expeditors International of Washington, Inc. reported a net income of 229.61M and revenue of 2.78B, resulting in a net margin of 8.3%.
WST - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, West Pharmaceutical Services, Inc. reported a net income of 154.00M and revenue of 872.30M, resulting in a net margin of 17.7%.
Frequently Asked Questions
EXPD and WST have a correlation of 0.33, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
WST has higher volatility (9.56%) compared to EXPD (7.19%). In terms of maximum drawdown, EXPD dropped -58.07% vs WST's -59.29%.
EXPD currently has the higher Sharpe Ratio (1.53 vs 1.28), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for EXPD and WST
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer